SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+12.89%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$245M
AUM Growth
+$245M
(+5.5%)
Cap. Flow
-$8.04M
Cap. Flow
% of AUM
-3.28%
Top 10 Holdings %
Top 10 Hldgs %
37.52%
Holding
47
New
9
Increased
11
Reduced
14
Closed
9
Top Buys
| 1 |
Tenet Healthcare
THC
|
$6.79M |
| 2 |
Elevance Health
ELV
|
$6.42M |
| 3 |
Cardinal Health
CAH
|
$5.36M |
| 4 |
Incyte
INCY
|
$5.22M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$4.83M |
Top Sells
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
$7.4M |
| 2 |
Cencora
COR
|
$5.82M |
| 3 |
Quest Diagnostics
DGX
|
$5.73M |
| 4 |
Merck
MRK
|
$4.98M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$3.9M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$427B
| $10.2M | 4.17% |
65,000
+5,000
| +8% | +$787K |
|
2
HCA Healthcare
HCA
$94.5B
| $9.87M | 4.02% |
60,000
| – | – |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.66M | 3.94% |
20,000
+10,000
| +100% | +$4.83M |
|
4
McKesson
MCK
$85.4B
| $9.57M | 3.9% |
55,000
+2,500
| +5% | +$435K |
|
5
Medtronic
MDT
$119B
| $9.37M | 3.82% |
80,000
+10,000
| +14% | +$1.17M |
|
6
Zimmer Biomet
ZBH
$21B
| $9.25M | 3.77% |
60,000
+5,000
| +9% | +$770K |
|
7
Universal Health Services
UHS
$11.6B
| $8.94M | 3.64% |
65,000
| – | – |
|
8
Danaher
DHR
$147B
| $8.89M | 3.62% |
40,000
-5,000
| -11% | -$1.11M |
|
9
Abbott
ABT
$231B
| $8.21M | 3.35% |
75,000
-15,000
| -17% | -$1.64M |
|
10
IQVIA
IQV
$32.4B
| $8.06M | 3.29% |
45,000
+15,000
| +50% | +$2.69M |
|
11
Stryker
SYK
$150B
| $7.35M | 3% |
30,000
| – | – |
|
12
Boston Scientific
BSX
$156B
| $7.19M | 2.93% |
200,000
+30,000
| +18% | +$1.08M |
|
13
Humana
HUM
$36.5B
| $7.18M | 2.93% |
17,500
-2,500
| -13% | -$1.03M |
|
14
Avantor
AVTR
$9.18B
| $7.04M | 2.87% |
250,000
| – | – |
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $7.02M | 2.86% |
80,000
+15,000
| +23% | +$1.32M |
|
16
UnitedHealth
UNH
$281B
| $7.01M | 2.86% |
20,000
-2,000
| -9% | -$701K |
|
17
Thermo Fisher Scientific
TMO
$186B
| $6.99M | 2.85% |
15,000
-5,000
| -25% | -$2.33M |
|
18
Molina Healthcare
MOH
$9.8B
| $6.91M | 2.82% |
32,500
-12,500
| -28% | -$2.66M |
|
19
Becton Dickinson
BDX
$55.3B
| $6.88M | 2.81% |
27,500
+11,500
| +72% | +$2.88M |
|
|
20
Tenet Healthcare
THC
$16.3B
| $6.79M | 2.77% |
+170,000
| New | +$6.79M |
|
21
Labcorp
LH
$23.1B
| $6.62M | 2.7% |
32,500
-7,500
| -19% | -$1.53M |
|
|
22
Elevance Health
ELV
$71.8B
| $6.42M | 2.62% |
+20,000
| New | +$6.42M |
|
23
Baxter International
BAX
$12.7B
| $6.02M | 2.45% |
75,000
-10,000
| -12% | -$802K |
|
24
Eli Lilly
LLY
$657B
| $5.91M | 2.41% |
35,000
-20,000
| -36% | -$3.38M |
|
25
Guardant Health
GH
$8.41B
| $5.8M | 2.36% |
45,000
+10,000
| +29% | +$1.29M |
|